1, 2, 4-OXADIAZOLE DERIVATIVES AS HPPAR ALPHA AGONISTS
A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: X is O or S; X is O or S; n is 1-3; One of Y and Z is N, and the other is O; R and R are independently halogen, H, CH3, OCH3 or C1-3 alkyl; Each R independently is halogen, CF3, C1-6 st...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LIU, KEVIN, GUANGCHENG GELLIBERT, FRANCOISE, JEANNE |
| description | A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: X is O or S; X is O or S; n is 1-3; One of Y and Z is N, and the other is O; R and R are independently halogen, H, CH3, OCH3 or C1-3 alkyl; Each R independently is halogen, CF3, C1-6 straight or branched alkyl; R and R are independently H or C1-3 alkyl. y is 0, 1, 2, 3, 4 or 5.
L'invention concerne un composé de la formule (I), ainsi que des sels, solvates et esters hydrolysables, pharmaceutiquement acceptables de ce composé. Dans la formule (I), X représente O ou S ; X représente O ou S ; n est compris entre 1 et 3 ; un des deux éléments Y et Z représente N, et l'autre représente O ; R et R représentent indépendamment halogène, H, CF3, OCH3 ou alkyle C1-3 ; chaque R représente indépendamment halogène, CF3, alkyle C1-6 linéaire ou ramifié ; R et R représentent indépendamment H ou alkyle C1-3. Y est 0, 1, 2, 3, 4 ou 5. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO0246174A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO0246174A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO0246174A13</originalsourceid><addsrcrecordid>eNrjZDAz1FEw0lEw0fWPcHTxdIzy93FVcHEN8gxzDPEMcw1WcAxW8AgIcAxScPQJ8HBUcHT39_MMDgnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx4f4GRiZmhuYmjobGRCgBAGXdJuY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1, 2, 4-OXADIAZOLE DERIVATIVES AS HPPAR ALPHA AGONISTS</title><source>esp@cenet</source><creator>LIU, KEVIN, GUANGCHENG ; GELLIBERT, FRANCOISE, JEANNE</creator><creatorcontrib>LIU, KEVIN, GUANGCHENG ; GELLIBERT, FRANCOISE, JEANNE</creatorcontrib><description>A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: X is O or S; X is O or S; n is 1-3; One of Y and Z is N, and the other is O; R and R are independently halogen, H, CH3, OCH3 or C1-3 alkyl; Each R independently is halogen, CF3, C1-6 straight or branched alkyl; R and R are independently H or C1-3 alkyl. y is 0, 1, 2, 3, 4 or 5.
L'invention concerne un composé de la formule (I), ainsi que des sels, solvates et esters hydrolysables, pharmaceutiquement acceptables de ce composé. Dans la formule (I), X représente O ou S ; X représente O ou S ; n est compris entre 1 et 3 ; un des deux éléments Y et Z représente N, et l'autre représente O ; R et R représentent indépendamment halogène, H, CF3, OCH3 ou alkyle C1-3 ; chaque R représente indépendamment halogène, CF3, alkyle C1-6 linéaire ou ramifié ; R et R représentent indépendamment H ou alkyle C1-3. Y est 0, 1, 2, 3, 4 ou 5.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020613&DB=EPODOC&CC=WO&NR=0246174A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020613&DB=EPODOC&CC=WO&NR=0246174A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU, KEVIN, GUANGCHENG</creatorcontrib><creatorcontrib>GELLIBERT, FRANCOISE, JEANNE</creatorcontrib><title>1, 2, 4-OXADIAZOLE DERIVATIVES AS HPPAR ALPHA AGONISTS</title><description>A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: X is O or S; X is O or S; n is 1-3; One of Y and Z is N, and the other is O; R and R are independently halogen, H, CH3, OCH3 or C1-3 alkyl; Each R independently is halogen, CF3, C1-6 straight or branched alkyl; R and R are independently H or C1-3 alkyl. y is 0, 1, 2, 3, 4 or 5.
L'invention concerne un composé de la formule (I), ainsi que des sels, solvates et esters hydrolysables, pharmaceutiquement acceptables de ce composé. Dans la formule (I), X représente O ou S ; X représente O ou S ; n est compris entre 1 et 3 ; un des deux éléments Y et Z représente N, et l'autre représente O ; R et R représentent indépendamment halogène, H, CF3, OCH3 ou alkyle C1-3 ; chaque R représente indépendamment halogène, CF3, alkyle C1-6 linéaire ou ramifié ; R et R représentent indépendamment H ou alkyle C1-3. Y est 0, 1, 2, 3, 4 ou 5.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAz1FEw0lEw0fWPcHTxdIzy93FVcHEN8gxzDPEMcw1WcAxW8AgIcAxScPQJ8HBUcHT39_MMDgnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx4f4GRiZmhuYmjobGRCgBAGXdJuY</recordid><startdate>20020613</startdate><enddate>20020613</enddate><creator>LIU, KEVIN, GUANGCHENG</creator><creator>GELLIBERT, FRANCOISE, JEANNE</creator><scope>EVB</scope></search><sort><creationdate>20020613</creationdate><title>1, 2, 4-OXADIAZOLE DERIVATIVES AS HPPAR ALPHA AGONISTS</title><author>LIU, KEVIN, GUANGCHENG ; GELLIBERT, FRANCOISE, JEANNE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO0246174A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIU, KEVIN, GUANGCHENG</creatorcontrib><creatorcontrib>GELLIBERT, FRANCOISE, JEANNE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU, KEVIN, GUANGCHENG</au><au>GELLIBERT, FRANCOISE, JEANNE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1, 2, 4-OXADIAZOLE DERIVATIVES AS HPPAR ALPHA AGONISTS</title><date>2002-06-13</date><risdate>2002</risdate><abstract>A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein: X is O or S; X is O or S; n is 1-3; One of Y and Z is N, and the other is O; R and R are independently halogen, H, CH3, OCH3 or C1-3 alkyl; Each R independently is halogen, CF3, C1-6 straight or branched alkyl; R and R are independently H or C1-3 alkyl. y is 0, 1, 2, 3, 4 or 5.
L'invention concerne un composé de la formule (I), ainsi que des sels, solvates et esters hydrolysables, pharmaceutiquement acceptables de ce composé. Dans la formule (I), X représente O ou S ; X représente O ou S ; n est compris entre 1 et 3 ; un des deux éléments Y et Z représente N, et l'autre représente O ; R et R représentent indépendamment halogène, H, CF3, OCH3 ou alkyle C1-3 ; chaque R représente indépendamment halogène, CF3, alkyle C1-6 linéaire ou ramifié ; R et R représentent indépendamment H ou alkyle C1-3. Y est 0, 1, 2, 3, 4 ou 5.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO0246174A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 1, 2, 4-OXADIAZOLE DERIVATIVES AS HPPAR ALPHA AGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A25%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU,%20KEVIN,%20GUANGCHENG&rft.date=2002-06-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO0246174A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |